Rifabutin pharmacokinetics and safety among TB/HIV-coinfected children receiving lopinavir/ritonavir-containing second-line ART

tel qu’imprimé : Holly E Rawizza

• University College Hospital, Ibadan (NG)
• University of Ibadan (NG)

• Jos University Teaching Hospital (NG)
• University of Jos (NG)

tel qu’imprimé : Emeka Ejeliogu

• Jos University Teaching Hospital (NG)
• University of Jos (NG)

• University College Hospital, Ibadan (NG)
• University of Ibadan (NG)

tel qu’imprimé : Babatunde O Ogunbosi

• Jos University Teaching Hospital (NG)
• University of Jos (NG)

• University College Hospital, Ibadan (NG)
• University of Ibadan (NG)

tel qu’imprimé : Georgina Odaibo

• Jos University Teaching Hospital (NG)
• University of Jos (NG)

• University College Hospital, Ibadan (NG)
• University of Ibadan (NG)

tel qu’imprimé : David Olaleye

• University of Cape Town (ZA)

tel qu’imprimé : Kristin M Darin

• AIDS Prevention Initiative in Nigeria (NG)

tel qu’imprimé : Phyllis J Kanki

• Institute of Infectious Disease and Molecular Medicine (ZA)
• Wellcome Centre for Infectious Diseases Research in Africa (ZA)
• University of Cape Town (ZA)

tel qu’imprimé : Helen M McIlleron